Breakout Stocks: Generex Biotechnology Corporation (OTCMKTS:GNBT) Up 31.15%, Houston American Energy Corporation (NYSEMKT:HUSA) Up 25.54%
Northern, WI 05/23/2013 (GDPInsider) – Generex Biotechnology Corporation (OTCMKTS:GNBT) has a strong showing today after starting the day at 0.03. Since opening dead level with the previous day’s close of 0.03, GNBT has posted a strong upward trend and is up 31.15%. The stock has seen a surge of activity with volume of 12.208 million, a whopping 755.50% increase upon average volume of 1.427 million shares. The strong trading has given GNBT a range of 0.0319 and 0.0410. GNBT has come alive and current market valuation sees it trading 33.33% above both its SMA50 and SMA20.
RSI is still healthy at 50.00, indicating of course that the stock is neither oversold nor overbought at current market valuation. Analysts have set a target of 6.00 for the stock and EPS is projected to grow this year by 68.24%. This growth will add to an underlying market cap of $8.13 million.
GNBT announced that it is slated to deliver three presentations demonstrating the superiority of the AE37 breast cancer vaccine being developed by its wholly-owned subsidiary, Antigen Express, Inc.
Is GNBT a solid investment at these levels? Get exclusive data and trends here.
Houston American Energy Corporation (NYSEMKT:HUSA) is up 25.54% after starting the day’s trading at 0.25 – level with its previous close of 0.25. The stock has a range of 0.2502 and 0.33 and is trading on strong volume of 1.131 million shares. Average volume by comparison is 291.42K which means that today’s activity signals breakout volume levels.
HUSA announced on May 10, 2013 that the Crown Paper #1 well, in which it has a 5.675% royalty stake, has a had a successful recompletion. The recompletion exercise was conducted by the well’s operator, Pennington Oil & Gas, LLC.
HUSA is up 40.52% on its 20-day simple moving average and 43.13% on its 50-day simple moving average. The recent uptrend means that HUSA is down 84.04% on its 52-week high of 1.88 but up 66.67% on its 52-week low of 0.18.
HUSA has a RSI of 67.42, indicating that despite the significant increases in market valuation, the stock has still not crossed over into overbought territory.
How Should Investors Trade HUSA Now? Get exclusive insights and updates here.
WallStreetAnalyzed.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit WallStreetAnalyzed.com website, for complete risks and disclosures.